Better use of bone scans in prostate cancer

被引：2
作者：
Larson, Steven M. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Mol Imaging & Therapy Serv, New York, NY 10065 USA
来源：
NATURE REVIEWS UROLOGY | 2015年 / 12卷 / 04期
关键词：
MANAGEMENT;
D O I：
10.1038/nrurol.2014.305
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Bone scanning for radiographical staging of prostate cancer is common; however, its current use in clinical practice is not in line with the published guidelines. A recent study comparing the performance of current practice with that of guideline recommendations found that following the American Urological Association guidelines consistently for newly diagnosed patients with prostate cancer would result in better outcomes.
引用
收藏
页码：190 / 191
页数：2
相关论文
共 50 条
  • [21] Investigation of risk factors for prostate cancer patients with bone metastasis based on clinical data
    Yamada, Yoshiaki
    Naruse, Katsuya
    Nakamura, Kogenta
    Taki, Tomohiro
    Tobiume, Motoi
    Zennami, Kenji
    Nishikawa, Genya
    Itoh, Youko
    Muramatsu, Yoshitaka
    Nanaura, Hiroshi
    Nishimura, Miho
    Takii, Kazuko
    Adham, Adnan Odhafa Kh.
    Honda, Nobuaki
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (04) : 635 - 639
  • [22] GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment
    Yamamichi, Gaku
    Kato, Taigo
    Arakawa, Noriaki
    Ino, Yoko
    Ujike, Takeshi
    Nakano, Kosuke
    Koh, Yoko
    Motoyama, Yuichi
    Outani, Hidetatsu
    Myoba, Shohei
    Ishizuya, Yu
    Yamamoto, Yoshiyuki
    Hatano, Koji
    Kawashima, Atsunari
    Fukuhara, Shinichiro
    Uemura, Hiroji
    Okada, Seiji
    Morii, Eiichi
    Nonomura, Norio
    Uemura, Motohide
    BIOMARKER RESEARCH, 2024, 12 (01)
  • [23] Reporting and Handling of Indeterminate Bone Scan Results in the Staging of Prostate Cancer: A Systematic Review
    Petersen, Lars J.
    Strandberg, Jesper
    Stenholt, Louise
    Johansen, Martin B.
    Zacho, Helle D.
    DIAGNOSTICS, 2018, 8 (01)
  • [24] Patterns of Bone Mineral Density Testing in Men Receiving Androgen Deprivation for Prostate Cancer
    Shahinian, Vahakn B.
    Kuo, Yong-Fang
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (11) : 1440 - 1446
  • [25] Assessment of a software for semi-automatically calculating the bone scan index on bone scintigraphy scans
    Yoshida, Atsushi
    Higashiyama, Shigeaki
    Kawabe, Joji
    CLINICAL IMAGING, 2021, 78 : 14 - 18
  • [26] An elevated serum miR-141 level in patients with bone-metastatic prostate cancer is correlated with more bone lesions
    Zhang, Hai-Liang
    Qin, Xiao-Jian
    Cao, Da-Long
    Zhu, Yao
    Yao, Xu-Dong
    Zhang, Shi-Lin
    Dai, Bo
    Ye, Ding-Wei
    ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (02) : 231 - 235
  • [27] Trends and Racial Differences in the Use of Androgen Deprivation Therapy for Metastatic Prostate Cancer
    Carson, April P.
    Howard, Daniel L.
    Carpenter, William R.
    Taylor, Yhenneko J.
    Peacock, Sharon
    Schenck, Anna P.
    Godley, Paul A.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 39 (05) : 872 - 881
  • [28] Increasing Use of Observation among Men at Low Risk for Prostate Cancer Mortality
    Ritch, Chad R.
    Graves, Amy J.
    Keegan, Kirk A.
    Ni, Shenghua
    Bassett, Jeffrey C.
    Chang, Sam S.
    Resnick, Matthew J.
    Penson, David F.
    Barocas, Daniel A.
    JOURNAL OF UROLOGY, 2015, 193 (03) : 801 - 806
  • [29] Enzalutamide: A Review of Its Use in Metastatic, Castration-Resistant Prostate Cancer
    Sanford, Mark
    DRUGS, 2013, 73 (15) : 1723 - 1732
  • [30] Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan
    Mitsuzuka, Koji
    Koga, Hirofumi
    Sugimoto, Mikio
    Arai, Yoichi
    Ohyama, Chikara
    Kakehi, Yoshiyuki
    Naito, Seiji
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (08) : 754 - 759
12345